BlackRock’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,545,458
Closed -$41.5M 5582
2025
Q2
$41.5M Sell
4,545,458
-115,614
-2% -$850K ﹤0.01% 2563
2025
Q1
$37.1M Sell
4,661,072
-189,645
-4% -$1.39M ﹤0.01% 2544
2024
Q4
$26.3M Sell
4,850,717
-540,196
-10% -$3.3M ﹤0.01% 2866
2024
Q3
$38.9M Buy
5,390,913
+175,324
+3% +$1.61M ﹤0.01% 2632
2024
Q2
$56.6M Buy
5,215,589
+323,427
+7% +$4.14M ﹤0.01% 2340
2024
Q1
$91.7M Buy
4,892,162
+228,262
+5% +$5.27M ﹤0.01% 2102
2023
Q4
$101M Buy
4,663,900
+447,305
+11% +$8.86M ﹤0.01% 2064
2023
Q3
$86.8M Sell
4,216,595
-207,611
-5% -$6M ﹤0.01% 2073
2023
Q2
$208M Sell
4,424,206
-505,580
-10% -$25.2M 0.01% 1548
2023
Q1
$207M Buy
4,929,786
+19,425
+0.4% +$835K 0.01% 1510
2022
Q4
$187M Buy
4,910,361
+88,298
+2% +$3.37M 0.01% 1580
2022
Q3
$189M Buy
4,822,063
+580,250
+14% +$22.4M 0.01% 1515
2022
Q2
$137M Buy
4,241,813
+1,487,597
+54% +$49.9M ﹤0.01% 1820
2022
Q1
$91.2M Sell
2,754,216
-25,221
-0.9% -$948K ﹤0.01% 2194
2021
Q4
$118M Sell
2,779,437
-95,118
-3% -$3.98M ﹤0.01% 2097
2021
Q3
$127M Buy
2,874,555
+24,057
+0.8% +$1.1M ﹤0.01% 2059
2021
Q2
$162M Sell
2,850,498
-460,570
-14% -$32.6M ﹤0.01% 1934
2021
Q1
$248M Buy
3,311,068
+400,798
+14% +$32.9M 0.01% 1581
2020
Q4
$252M Sell
2,910,270
-83,586
-3% -$6.16M 0.01% 1438
2020
Q3
$183M Sell
2,993,856
-191,457
-6% -$9.7M 0.01% 1452
2020
Q2
$132M Buy
3,185,313
+438,396
+16% +$15.9M 0.01% 1656
2020
Q1
$78.9M Sell
2,746,917
-38,331
-1% -$2.22M ﹤0.01% 1789
2019
Q4
$201M Buy
2,785,248
+14,549
+0.5% +$1.79M 0.01% 1483
2019
Q3
$389M Buy
2,770,699
+21,986
+0.8% +$3.68M 0.02% 926
2019
Q2
$503M Buy
2,748,713
+75,246
+3% +$12.8M 0.02% 737
2019
Q1
$425M Buy
2,673,467
+162,976
+6% +$23.6M 0.02% 838
2018
Q4
$240M Sell
2,510,491
-305,919
-11% -$35M 0.01% 1180
2018
Q3
$398M Buy
2,816,410
+23,862
+0.9% +$3.68M 0.02% 928
2018
Q2
$437M Sell
2,792,548
-981,735
-26% -$154M 0.02% 829
2018
Q1
$608M Buy
3,774,283
+330,112
+10% +$56M 0.03% 601
2017
Q4
$567M Buy
3,444,171
+486,135
+16% +$47.1M 0.03% 642
2017
Q3
$184M Sell
2,958,036
-73,512
-2% -$5.77M 0.01% 1427
2017
Q2
$241M Buy
3,031,548
+168,424
+6% +$12.2M 0.01% 1138
2017
Q1
$203M Buy
2,863,124
+2,835,006
+10,083% +$166M 0.01% 1279
2016
Q4
$1.44M Sell
28,118
-12,368
-31% -$583K ﹤0.01% 1358
2016
Q3
$1.86M Buy
40,486
+23,422
+137% +$953K ﹤0.01% 1239
2016
Q2
$514K Buy
17,064
+16,167
+1,802% +$539K ﹤0.01% 1660
2016
Q1
$29K Buy
897
+541
+152% +$19K ﹤0.01% 2656
2015
Q4
$21K Buy
356
+50
+16% +$2.48K ﹤0.01% 2550
2015
Q3
$13K Hold
306
﹤0.01% 2612
2015
Q2
$22K Buy
306
+167
+120% +$10.7K ﹤0.01% 2364
2015
Q1
$7K Sell
139
-7,000
-98% -$301K ﹤0.01% 2923
2014
Q4
$261K Buy
7,139
+239
+3% +$8.91K ﹤0.01% 1451
2014
Q3
$217K Buy
+6,900
New +$200K ﹤0.01% 1507

Other funds holding SAGE